{"version":"1.0","provider_name":"Medtechlabs","provider_url":"https:\/\/www.medtechlabs.se\/sv\/","author_name":"hamren","author_url":"https:\/\/www.medtechlabs.se\/sv\/author\/hamren\/","title":"Intervju med Br\u00f6stcancerf\u00f6rbundets Elisabet Schesny - Medtechlabs","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"kbf6AXRzod\"><a href=\"https:\/\/www.medtechlabs.se\/sv\/intervju-med-brostcancerforbundets-elisabet-schesny\/\">Intervju med Br\u00f6stcancerf\u00f6rbundets Elisabet Schesny<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.medtechlabs.se\/sv\/intervju-med-brostcancerforbundets-elisabet-schesny\/embed\/#?secret=kbf6AXRzod\" width=\"600\" height=\"338\" title=\"\u201dIntervju med Br\u00f6stcancerf\u00f6rbundets Elisabet Schesny\u201d &ndash; Medtechlabs\" data-secret=\"kbf6AXRzod\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.medtechlabs.se\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.medtechlabs.se\/wp-content\/uploads\/2023\/03\/Portrattbild-Elisabet-Schesny-Brostcancerforbundet.jpeg","thumbnail_width":1280,"thumbnail_height":1280,"description":"Hej Elisabeth, vad kommer ni att arbeta med under val\u00e5ret? \u2013 Vi fokuserar p\u00e5 kravet om j\u00e4mlik v\u00e5rd som \u00e4r otroligt viktigt f\u00f6r v\u00e5rt f\u00f6rbund. Det inneb\u00e4r att vi lyfter fr\u00e5gor om inf\u00f6rande av metoder f\u00f6r individualiserad screening baserad p\u00e5 kvinnans risk att utveckla br\u00f6stcancer (idag f\u00e5r alla samma screening genom mammografiprogrammet), alla patienters r\u00e4tt [&hellip;]"}